date:Aug 28, 2012
Clasado, formerly UK-based, but now registered in Malta, first had its prebiotic, article 13.5 claims rejected in 2009, provoking it to a fresh article 13.5 resubmission last year.
That too was rejected in December 2011 with eight human intervention studies, two human observational studies and three non-human studies failing to impress the EUs central food science agency that the formulation could ease gastrointestinal discomfort.
Appealing this, Clasado questioned the ruling of EFSAs Panel on